Students and staff from Lima's Catholic schools weren't about to let a little rain stop them on Friday. They walked the halls ...

GLP-1 weight-loss drugs alter brain circuits in the amygdala and dopamine system to reduce the motivation to seek out high-calorie foods.

Addiction is a complex disorder that lies at the intersection of neuroscience, psychiatry, psychology, and philosophy. While significant progress has been ...

When it comes to dopamine, we act like kids in a candy store. But instead of overindulging, experts suggest looking for ...

A landmark trial found social media companies liable for designing addictive products. Nicola J Kalk and Ben Carter look at ...

North Texas researchers identify gene changes in brain reward circuits that may point to new treatments for those struggling ...

Studies have shown that GLP-1s such as Ozempic or Wegovy can help people who are at risk of, or currently dealing with, ...

A signaling pathway best known for shaping the brain before birth also helps govern how adults learn, adapt, and persist in their behavior, according to new research co-led by Andreas H. Kottmann, ...

The Rachel Defends You podcast, hosted by Rachel Kugel of The Kugel Law Firm, continues to offer meaningful conversations that go beyond the courtroom, exploring how resilience, recovery, and personal ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

Researchers analyzed nationally representative, cross-sectional survey data from 195,543 adults aged 18 years and older in England, collected between January 2014 and December 2023. Five indicators of ...

A new paper in Nicotine and Tobacco Research, published by Oxford University Press, finds that people experiencing more economic disadvantages are more likely to smoke cigarettes, have higher levels ...